Prostate Cancer Trial, Recruiting NCT07597798 Sponsor: University College, London Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT07597798
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Men aged between 18 and 79, from any ethnic background, who have been diagnosed with a specific stage of prostate cancer (classified as cT2–T3a, with no spread to nearby lymph nodes or other parts of the body)
  • People who had a specialised prostate MRI scan (called an mpMRI) done before their prostate biopsy
  • People who are healthy enough to undergo a type of prostate removal surgery performed with robotic assistance (called RARP)
  • People whose biopsy results and MRI scan are of good enough quality to help plan the surgery
  • People who are already scheduled for this type of robotic prostate surgery, where the surgical team has recommended preserving the nerve bundles involved in erections, based on team discussions and scan and biopsy results
  • Men who are sexually active and have no or only mild erection difficulties before the trial, based on a specific questionnaire score (IIEF-EFD score of 24 or higher)
  • People who want to preserve their ability to have erections for sexual intercourse
  • People who are able to read English well enough to understand the study information and give their informed agreement to take part

Who may not be able to join:

  • People who already have moderate or severe erection difficulties (IIEF-EFD score below 24)
  • People who received hormone-reducing therapy (androgen deprivation therapy) before surgery
  • People who have previously had surgery for a non-cancerous enlarged prostate
  • People who have already received any treatment for prostate cancer, including external radiotherapy, internal radiation (brachytherapy), targeted local treatment (focal therapy), or chemotherapy
  • People who have had a previous pelvic injury involving a fracture, or a penile fracture
  • People who have previously had surgery to treat erection difficulties
  • People whose prostate MRI scan was of poor quality, or who only had a type of MRI scan done without contrast dye
  • People who have an established blood vessel or circulation condition, such as heart disease, a history of stroke, or problems with blood flow in the legs or other areas (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 January 2026
Est. completion
15 July 2027

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Number of Participants Enrolled During the Recruitment Period; Percentage of Participants Completing Follow-up Through 12 Months; Percentage of Participants With Accessory Pudendal Artery Identified on Pre-operative mpMRI

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov